CLINICAL_TRIALS
trial_result
· 2022-11-21
Clinical Trial Update: Efficacy and Safety Study of Postsurgical Analgesia With INL-001 in Abdominoplasty [Phase 3]
Summary
Phase 3 trial completed evaluating INL-001 for postsurgical analgesia in abdominoplasty, assessing efficacy and safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Innocoll | Conditions: Pain, Postoperative, Abdominoplasty | Phase 3 | Status: COMPLETED